Bellicum Pharmaceuticals, Inc. Profile Avatar - Palmy Investing

Bellicum Pharmaceuticals, Inc.

Bellicum Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel cellular immunotherapies for the treatment of hematological cancers and solid tumors in the United States and internationally. The com…

Biotechnology
US, Houston [HQ]

Lobbying Analysis

Bellicum Pharmaceuticals, Inc. has no lobbying expenses in our database.

History

Download
FY Quarter Expense For Lobby Disclosure LDA Reference
No data
End of BLCM's Analysis
CIK: 1358403 CUSIP: 079481404 ISIN: US0794814048 LEI: - UEI: -
Secondary Listings
BLCM has no secondary listings inside our databases.